Inhalation devices for the treatment of asthma--how much do paediatricians know about their correct use?

H Kurz1, J Riedler

  • 1Kinderinterne Abteilung, Sozialmedizinisches Zentrum Ost, Wien, Austria.

Insights

Paediatricians demonstrate acceptable knowledge of inhalation devices for childhood asthma treatment. However, practical skills require improvement, highlighting a need for enhanced training in using devices like Metered Dose Inhalers (MDIs) and nebulisers.

Area of Science:

  • Pediatrics
  • Respiratory Medicine
  • Medical Education

Background:

  • Childhood asthma requires effective inhalation therapy.
  • Proper use of inhalation devices is crucial for treatment success.
  • Assessing healthcare provider knowledge is essential for optimizing patient care.

Purpose of the Study:

  • To evaluate the practical and theoretical knowledge of paediatricians regarding inhalation devices for pediatric asthma.
  • To identify specific deficits in device handling and understanding among paediatricians.
  • To determine the need for improved training in inhalation device use for childhood asthma.

Main Methods:

  • A study involving 41 paediatricians from Austria and Switzerland.
  • Assessment of knowledge on four inhalation devices: Diskhaler, Metered Dose Inhaler (MDI) with Aerochamber, Aerochamber cleaning, and Pari Junior jet nebuliser.
  • Evaluation of both practical performance and theoretical understanding using a 1-5 scoring system.

Main Results:

  • Overall performance was acceptable, with a median score of 13 out of a possible 20.
  • Some paediatricians exhibited deficits in the practical application of specific inhalation devices.
  • Knowledge gaps were identified in the correct usage and maintenance of certain devices.

Conclusions:

  • While paediatricians possess a baseline understanding of inhalation devices, practical skills need enhancement.
  • Targeted training programs focusing on the correct use of various inhalation devices are recommended.
  • Improving paediatrician proficiency in inhalation therapy can lead to better outcomes for children with asthma.

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...